Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.3 (
collagenase
)
18,340
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ultraviolet (UV) irradiation regulates UV-responsive genes, including matrix metalloproteinases (MMPs). Moreover, UV-induced MMPs cause connective tissue damage and the skin to become wrinkled and aged. Here, we investigated the effect of eicosapentaenoic acid (EPA), a dietary omega-3 fatty acid, on UV-induced
MMP-1
expression in human dermal fibroblasts (HDFs). We found that UV radiation increases
MMP-1
expression and that this is mediated by p44 and p42 MAP kinase (ERK) and Jun-N-terminal kinase (JNK) activation but not by p38 activation. Pretreatment of HDFs with EPA inhibited UV-induced
MMP-1
expression in a dose-dependent manner and also inhibited the UV-induced activation of ERK and JNK by inhibiting ERK kinase (MEK1) and
SAPK/ERK kinase 1
(
SEK1
) activation, respectively. Moreover, inhibition of ERK and JNK by EPA resulted in the decrease of c-Fos expression and c-Jun phosphorylation/expression induced by UV, respectively, which led to the inhibition of UV-induced activator protein-1 DNA binding activity. This inhibitory effect of EPA on
MMP-1
was not mediated by an antioxidant effect. We also found that EPA inhibited 12-O-tetradecanoylphorbol-13-acetate- or tumor necrosis factor-alpha-induced
MMP-1
expression in HDFs and UV-induced
MMP-1
expression in HaCaT cells. In conclusion, our results demonstrate that EPA can inhibit UV-induced
MMP-1
expression by inhibiting the MEK1/ERK/c-Fos and
SEK1
/JNK/c-Jun pathways. Therefore, EPA is a potential agent for the prevention and treatment of skin aging.
...
PMID:Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. 1593 May 17